Mentz, Michael
Keay, William http://orcid.org/0000-0002-8794-7322
Strobl, Carolin Dorothea http://orcid.org/0000-0003-2257-6281
Antoniolli, Martina http://orcid.org/0000-0003-2720-9886
Adolph, Louisa
Heide, Michael
Lechner, Axel
Haebe, Sarah
Osterode, Elisa http://orcid.org/0000-0003-4359-2096
Kridel, Robert http://orcid.org/0000-0003-0287-7124
Ziegenhain, Christoph http://orcid.org/0000-0003-2208-4877
Wange, Lucas Esteban http://orcid.org/0000-0002-3275-9156
Hildebrand, Johannes Adrian http://orcid.org/0000-0002-5451-8038
Shree, Tanaya http://orcid.org/0000-0003-0694-3512
Silkenstedt, Elisabeth
Staiger, Annette M. http://orcid.org/0000-0002-5896-3200
Ott, German
Horn, Heike
Szczepanowski, Monika
Richter, Julia http://orcid.org/0000-0002-9543-4084
Levy, Ronald
Rosenwald, Andreas
Enard, Wolfgang
Zimber-Strobl, Ursula http://orcid.org/0000-0002-9765-5251
von Bergwelt-Baildon, Michael
Hiddemann, Wolfgang
Klapper, Wolfram http://orcid.org/0000-0001-7208-4117
Schmidt-Supprian, Marc
Rudelius, Martina
Bararia, Deepak
Passerini, Verena
Weigert, Oliver http://orcid.org/0000-0002-0987-7373
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (SCHM2440/8-1, WE 4679/2-1)
Deutsche Krebshilfe (110659, 70112997)
Else Kröner-Fresenius-Stiftung (2021_EKES.13)
Article History
Received: 13 February 2022
Revised: 21 June 2022
Accepted: 29 June 2022
First Online: 18 July 2022
Competing interests
: This research was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), Project-ID WE 4679/2-1 (OW), SCHM2440/8-1 (MSS), and the Max-Eder Program of the Deutsche Krebshilfe e.V. (DKH, German Cancer Aid), Project-ID 110659/70112997 (OW). OW is supported by an Else-Kröner Excellence Fellowship from the Else-Kröner-Fresenius Stiftung (Project-ID 2021_EKES.13). LA is supported by the Else Kröner-Fresenius Clinician Scientist Program: Cancer immunotherapy, and the Munich Clinician Scientist Program (MCSP). LA and JAH are supported by the German Consortium for Translational Cancer Research (DKTK) School of Oncology. MS, Amgen, Speakers Bureau. The authors declare no competing interests.